Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Warfarin - Accu-Break Pharmaceuticals/Alembic Pharmaceuticals

Next Previous
Drug Profile

Warfarin - Accu-Break Pharmaceuticals/Alembic Pharmaceuticals

Alternative Names: Accu-Break Warfarin Potassium; Accu-Break-formatted anticoagulant

Latest Information Update: 20 Nov 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Accu-Break Pharmaceuticals
  • Developer Accu-Break Pharmaceuticals; Alembic
  • Class Anti-ischaemics; Anticoagulants; Coumarins
  • Mechanism of Action Vitamin K antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Thromboembolism

Most Recent Events

  • 07 Dec 2018 No development reported - Preregistration for Thromboembolism in USA (PO)
  • 22 Nov 2015 Warfarin - Accu-Break Pharmaceuticals/Alembic Pharmaceuticals is available for licensing in USA, World as of 19 Nov 2015. www.accubreakpharmaceuticals.com
  • 19 Nov 2015 Preregistration for Thromboembolism in USA (PO) before November 2015

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top